TrialClinIQ
PrivateLast Round
Pre Seed
Apr 28, 2026
Total Funding Raised
$150,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
TrialClinIQ is a health tech company that provides an AI-powered clinical trial recruitment platform to connect community health centers with clinical research.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, EHR & EMR, Medical AI, Patient Engagement, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TrialClinIQ Comparables
Compare TrialClinIQ with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kitsa | 84% | |
| Dyania Health | 78% | |
| Tempus | 76% |
TrialClinIQ Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Apr 28, 2026 |
TrialClinIQ Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Caduceus Capital Partners | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
$150K round led by Caduceus Capital Partners
TrialClinIQ Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TrialClinIQ's valuation, stock price, and market status.
Is TrialClinIQ a public or private company?
TrialClinIQ is a private company.
What is the current stock price of TrialClinIQ?
TrialClinIQ is a private company with no public stock price. No recent secondary market data is available.
How much is TrialClinIQ worth (valuation)?
Valuation information for TrialClinIQ is not publicly available.
Can I buy TrialClinIQ stock?
TrialClinIQ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TrialClinIQ's last funding round?
TrialClinIQ's most recent funding round was Pre Seed on April 28, 2026.
Who are the main investors in TrialClinIQ?
Key investors in TrialClinIQ include Caduceus Capital Partners.
Will TrialClinIQ IPO soon?
No public IPO plans have been announced for TrialClinIQ.
How can I track TrialClinIQ secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TrialClinIQ's secondary market activity and sign up for updates.